29 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
. If Apexigen’s product candidates are approved, Apexigen may hire sales representatives and conduct physician and patient association outreach activities … not to exceed $540,000.
Following the Closing Date, it is expected that Pyxis Oncology will hire Dr. Yang as its interim head of research and development
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
full or part time); (ii) work location; (iii) employing entity; (iv) hire date; (v) status as exempt or non-exempt from wage and hour requirements … , (F) grant any awards under the Company Plans or any other equity or equity-based compensation, (G) hire or engage any officers or employees; provided
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
or part time); (ii) work location; (iii) employing entity; (iv) hire date; (v) status as exempt or non-exempt from wage and hour requirements; (vi … ) grant any awards under the Company Plans or any other equity or equity-based compensation, (G) hire or engage any officers or employees; provided
424B3
xihnzw7 ttfitrjd45l
10 Apr 23
Prospectus supplement
4:03pm
424B3
i88ykno
10 Apr 23
Prospectus supplement
4:02pm
POS AM
n31rpocc l6
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
7fuljps
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
0rhez7e7zc0uuohqz
9 Sep 22
Prospectus supplement
4:40pm
424B3
du1xdcqd9 omlppgp
9 Sep 22
Prospectus supplement
4:38pm
8-K/A
EX-99.2
8az661ddgkt xifvdc
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K
EX-10.6
w2e3x8 rn2
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm